# A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

> **NCT02608450** · PHASE3 · COMPLETED · sponsor: **Cassiopea SpA** · enrollment: 708 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** CB-03-01 cream, 1%
- **DRUG:** Vehicle cream

## Key facts

- **NCT ID:** NCT02608450
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-21
- **Primary completion:** 2018-04-11
- **Final completion:** 2018-04-11
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608450, "A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02608450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*